Yearly Archives: 2005

1 in 120 people newly diagnosed with diabetes age 50 and older have a higher risk of developing pancreatic cancer--a risk that is eight times more than expected for the general population.

Research into a new treatment for nerve damage caused by diabetes could bring relief to millions of diabetic patients, say experts.

A study has shown that a protein found in fat cells is a newly discovered cause of insulin resistance.

Researchers report the discovery of a trigger for insulin resistance in the liver.

A new review of studies confirms that the drug metformin should be in the first line of defense against type 2 diabetes.

Initial results show that drug may reduce the risk of moderate vision loss, especially in patients with diabetic macular edema.

Obese men may not process carbohydrates as efficiently as obese women, a condition that can, ultimately, lead to a decrease in fitness level and the development of metabolic disorders.

Adult lifestyle has more influence on your chances of developing diabetes than childhood experience, according to new research whose findings contradict previously-held beliefs.

Joslin Diabetes Center has launched a new affiliation program designed to bring Joslin's world-class vision resources to local communities across the United States and beyond.

In people with diabetes, diuretics work as well as ACE-inhibitors and calcium channel blockers in protecting against heart attack and improving survival, and offer more protection against congestive heart failure.

regular yoga practice may help prevent middle-age spread in normal-weight people and may promote weight loss in those who are overweight.

Although numerous studies have shown that low-grade inflammation is linked to heart disease and diabetes, more recent studies have shown that inflammation plays a role in insulin resistance, a syndrome that leads to diabetes and heart disease.

Research showed that therapies targeting abdominal fat tissue, such as weight loss, may provide a new approach to treat asthma.

Diabetic retinopathy has been found in nearly 8 percent of pre-diabetic study participants. It was also seen in 12 percent of participants with type 2 diabetes who developed diabetes during the program.

Results of a study demonstrate that patients with type 2 diabetes can safely achieve target blood sugar levels faster and more frequently when insulin glargine is added to therapy, versus using oral agents alone.

A new study may help more people save their limbs. It's the first-ever large study of how foot-bone infection, called osteomyelitis, is typically treated and how well the different approaches work.